These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 35175608)

  • 1. Breast Cancer Stem Cells: A Clinician's View.
    Schneider J; Vizoso FJ
    Methods Mol Biol; 2022; 2471():345-349. PubMed ID: 35175608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mammary Stem Cells: A Clinician's View.
    Schneider J
    Methods Mol Biol; 2015; 1293():267-71. PubMed ID: 26040694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer stem cells: are we ready to go from bench to bedside?
    Lin CY; Barry-Holson KQ; Allison KH
    Histopathology; 2016 Jan; 68(1):119-37. PubMed ID: 26768034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer stem cells: implications for therapy of breast cancer.
    Morrison BJ; Schmidt CW; Lakhani SR; Reynolds BA; Lopez JA
    Breast Cancer Res; 2008; 10(4):210. PubMed ID: 18671830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in the knowledge of breast cancer stem cells. A review.
    Schwarz-Cruz Y Celis A; Espinosa M; Maldonado V; Melendez-Zajgla J
    Histol Histopathol; 2016 Jun; 31(6):601-12. PubMed ID: 26715540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of CXCR7 inhibits proliferative capacity and stem cell-like properties in breast cancer stem cells.
    Tang X; Li X; Li Z; Liu Y; Yao L; Song S; Yang H; Li C
    Tumour Biol; 2016 Oct; 37(10):13425-13433. PubMed ID: 27460092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer stem cells: Features, key drivers and treatment options.
    Dittmer J
    Semin Cancer Biol; 2018 Dec; 53():59-74. PubMed ID: 30059727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer stem cells: treatment resistance and therapeutic opportunities.
    Al-Ejeh F; Smart CE; Morrison BJ; Chenevix-Trench G; López JA; Lakhani SR; Brown MP; Khanna KK
    Carcinogenesis; 2011 May; 32(5):650-8. PubMed ID: 21310941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer stem cell in breast cancer therapeutic resistance.
    Bai X; Ni J; Beretov J; Graham P; Li Y
    Cancer Treat Rev; 2018 Sep; 69():152-163. PubMed ID: 30029203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity and Plasticity of Breast Cancer Stem Cells.
    Sousa B; Ribeiro AS; Paredes J
    Adv Exp Med Biol; 2019; 1139():83-103. PubMed ID: 31134496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Menopausal status, adipose tissue, and breast cancer risk: impact of estrogen replacement therapy.
    Eden JA
    Horm Mol Biol Clin Investig; 2013 Aug; 14(2):57-63. PubMed ID: 25436720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast cancer stem cells: obstacles to therapy.
    Smalley M; Piggott L; Clarkson R
    Cancer Lett; 2013 Sep; 338(1):57-62. PubMed ID: 22554712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs and breast cancer stem cells: Potential role in breast cancer therapy.
    Vahidian F; Mohammadi H; Ali-Hasanzadeh M; Derakhshani A; Mostaan M; Hemmatzadeh M; Baradaran B
    J Cell Physiol; 2019 Apr; 234(4):3294-3306. PubMed ID: 30362508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stem cells of the breast and cancer therapy.
    Groner B; Vafaizadeh V; Brill B; Klemmt P
    Womens Health (Lond); 2010 Mar; 6(2):205-19. PubMed ID: 20187727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EMMPRIN Down-regulating miR-106a/b Modifies Breast Cancer Stem-like Cell Properties via Interaction with Fibroblasts Through STAT3 and HIF-1α.
    Liu Y; Zhang J; Sun X; Li M
    Sci Rep; 2016 Jun; 6():28329. PubMed ID: 27325313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding EGFR Signaling in Breast Cancer and Breast Cancer Stem Cells: Overexpression and Therapeutic Implications.
    Alanazi IO; Khan Z
    Asian Pac J Cancer Prev; 2016; 17(2):445-53. PubMed ID: 26925626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer stem cells, heterogeneity, targeting therapies and therapeutic implications.
    Zeng X; Liu C; Yao J; Wan H; Wan G; Li Y; Chen N
    Pharmacol Res; 2021 Jan; 163():105320. PubMed ID: 33271295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance to endocrine therapy: are breast cancer stem cells the culprits?
    O'Brien CS; Howell SJ; Farnie G; Clarke RB
    J Mammary Gland Biol Neoplasia; 2009 Mar; 14(1):45-54. PubMed ID: 19252972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer stem cell hypothesis: clinical relevance (answering breast cancer clinical features).
    Rodríguez Salas N; González González E; Gamallo Amat C
    Clin Transl Oncol; 2010 Jun; 12(6):395-400. PubMed ID: 20534394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation of breast cancer stem cells by knockdown of CD44: promising differentiation therapy.
    Pham PV; Phan NL; Nguyen NT; Truong NH; Duong TT; Le DV; Truong KD; Phan NK
    J Transl Med; 2011 Dec; 9():209. PubMed ID: 22152097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.